Researchers have developed a minimally invasive 'intelligent tattoo' for the early detection of melanoma.

The Chronicle of Skin & Allergy, in partnership with the Dermatology Industry Taskforce on Inclusion, Diversity and Equity (DiTiDE), is pleased to announce the winners of the 4rd annual short essay competition for Canadian dermatology residents. This contest was open to any resident enrolled in a dermatology training program at a Canadian medical school, with enrolment confirmed by their Program Director. Entrants submitted a 350- to 500-word composition reflecting their view

A highly magnified view of melanoma tumours growing in the skin. CD169+ macrophages are shown in green and yellow, forming a biological boundary wall to contain the tumours. Image courtesy Garvan Institute of Medical Research For the first time, researchers have observed macrophages attacking melanoma cells in real time and identified a subpopulation of the immune cells involved in resisting the skin cancer. The findings, published in the Journal of Experimental Medicine, rev

Concomitant ixekizumab and tirzepatide improved skin clearance and reductions in weight in patients with moderate-to-severe psoriasis

Staphylococcus aureus. Photo by Janice Haney Carr, provided by CDC/ Matthew J. Arduino, DRPH, via Wikimedia Commons New findings suggest that commensal bacteria on the skin release molecules that inhibit the skin’s production of pro-inflammatory interleukin (IL)-33, potentially preventing atopic dermatitis (AD) flares. Published in Nature Communications, the findings come from research conducted at the University of Manchester and Tokyo University of Agriculture and Technolog

Risankizumab was associated with a lower risk of serious infections when compared to other systemic treatments for psoriasis